SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-261688
Filing Date
2023-10-24
Accepted
2023-10-24 16:21:01
Documents
12
Period of Report
2023-10-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d550842d8k.htm   iXBRL 8-K 25314
  Complete submission text file 0001193125-23-261688.txt   151216

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20231024.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20231024_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20231024_pre.xml EX-101.PRE 11713
6 EXTRACTED XBRL INSTANCE DOCUMENT d550842d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 231342921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences